Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000085925 | SCV000515217 | pathogenic | not provided | 2024-02-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18925668, 1642278, 28976636, 31589614, 33599182, 29345414, 8434585) |
Genetic Services Laboratory, |
RCV000003997 | SCV000597781 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 2016-12-14 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763287 | SCV000893934 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B; Ocular albinism with congenital sensorineural hearing loss; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Pele Pequeno Principe Research Institute, |
RCV000003997 | SCV000998906 | pathogenic | Tyrosinase-negative oculocutaneous albinism | criteria provided, single submitter | research | ||
Ambry Genetics | RCV001267064 | SCV001445245 | pathogenic | Inborn genetic diseases | 2018-02-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000003997 | SCV001821919 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085925 | SCV002229417 | pathogenic | not provided | 2024-01-10 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 47 of the TYR protein (p.Gly47Asp). This variant is present in population databases (rs61753180, gnomAD 0.1%). This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 1676041, 8128955, 8434585, 16417222, 19626598, 23242301, 23882993, 28976636). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Puerto Rican or Moroccan Jewish ancestry (PMID: 8128955, 8434585, 16417222, 23882993). ClinVar contains an entry for this variant (Variation ID: 3794). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. This variant disrupts the p.Gly47 amino acid residue in TYR. Other variant(s) that disrupt this residue have been observed in individuals with TYR-related conditions (PMID: 8434585, 26167114, 29345414), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003460421 | SCV004207551 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2024-03-20 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000003997 | SCV000024163 | pathogenic | Tyrosinase-negative oculocutaneous albinism | 2008-11-15 | no assertion criteria provided | literature only | |
OMIM | RCV000003998 | SCV000024164 | pathogenic | Oculocutaneous albinism type 1B | 2008-11-15 | no assertion criteria provided | literature only | |
Retina International | RCV000085925 | SCV000118068 | not provided | not provided | no assertion provided | not provided | ||
Prevention |
RCV004532284 | SCV004114982 | pathogenic | TYR-related disorder | 2024-07-26 | no assertion criteria provided | clinical testing | The TYR c.140G>A variant is predicted to result in the amino acid substitution p.Gly47Asp. This variant has been reported many times as causative for autosomal recessive oculocutaneous albinism (see for examples Oetting et al. 1993. PubMed ID: 8434585; Gershoni-Baruch et al. 1994. PubMed ID: 8128955; Camand et al. 2001. PubMed ID: 11295837; Marti et al. 2017. PubMed ID: 28976636). This variant is reported in 0.11% of alleles in individuals of Latino descent in gnomAD. This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/3794). Given all the evidence, we interpret this variant as pathogenic. |